CTTC

Since the inception of the Ancora Innovations partnership in 2018, Vanderbilt and Deerfield Management have enjoyed a robust collaboration. Deerfield’s commitment includes significant support for advancing translational research and sponsorship of various events across Vanderbilt University and Vanderbilt University Medical Center. Recently, key members of Deerfield's leadership team spent two days at Vanderbilt to engage faculty in discussions about potential projects of mutual interest.  Read More

Vanderbilt University announced nine recipients of the Innovation Catalyst Fund awards for the June 2025 cycle, continuing its mission of accelerating translational research and driving innovative solutions to real-world challenges by providing faculty with crucial pre-seed funding across diverse disciplines.  The newly selected projects span cutting-edge work in health care, engineering and technology solutions. Read More

"Hosting Nissha Medical Technologies at the former site of our Stadium Club on West End Avenue will give our faculty and students extraordinary new opportunities to work with a leader in advancing medical devices—a strategic research priority for Vanderbilt and our region," Chancellor Daniel Diermeier said during a news conference on campus announcing the partnership. Read More

Vanderbilt University and its Center for Technology Transfer and Commercialization hosted the inaugural Southeast Venture Showcase, a first-of-its kind collaboration among top research universities and federal laboratories across the Southeast to highlight their most promising new technology-based ventures.  Read More

The Center for Technology Transfer and Commercialization has honored five faculty members as 2024 Master Innovators for their groundbreaking research and transformative innovations. These pioneers, recognized for achievements spanning patents, startups and impactful technologies, exemplify Vanderbilt's dedication to translating academic excellence into societal advancements. Read More

Vanderbilt University has awarded a new cycle of Innovation Catalyst Fund grants to pioneering faculty projects that advance health care technology, AI tools for research impact and wearable devices. These grants support translational research and drive real-world solutions across disciplines, underscoring Vanderbilt's commitment to fostering innovation and societal impact. Read More

Infectious diseases pose a significant global health challenge, accounting for a substantial proportion of deaths worldwide, according to recent data from the World Health Organization. Vanderbilt’s Life Science Showcase: Advancing Innovation in Infectious Diseases held on July 18 emphasized the vital importance of advancing research and innovation to combat these persistent threats. Read More

Vanderbilt has announced the February 2024 Innovation Catalyst Fund awardees, propelling groundbreaking research into practical applications. Read More

Donna Ingles, director of operations for the Vanderbilt Center for Technology Transfer and Commercialization, has been named to the 2024 Young American Leaders Program at Harvard Business School by the Global Action Platform. She was one of 10 local leaders chosen for the program, which aims to create a biomedical economic development strategy for the region using cluster models devised by Harvard economist Michael Porter. Read More

Vanderbilt University’s Center for Technology Transfer and Commercialization has launched the Concept Submission Form, a simple online tool aimed at streamlining the process for faculty to submit innovative ideas with potential for patenting and commercialization. Read More

The Vanderbilt Innovation Catalyst Fund honors eight projects in its inaugural pre-seed funding round, showcasing the university’s commitment to transforming research into real-world solutions. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

Chris Rowe, executive director for industry collaborations within Vanderbilt's Office of the Vice Provost for Research and Innovation and professor of the practice of engineering management, has been chosen for the 2023 Young American Leaders Program at Harvard Business School. He’ll join a task force focused on enhancing Nashville's biomedical sector, using cluster models to drive economic growth and innovation. Read More

Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read More

An optical imaging technology developed by Orrin H. Ingram Professor of Biomedical Engineering Anita Mahadevan-Jansen and her group, in partnership with a medical device company, has been selected as a finalist for the 2019 R&D 100 Awards. Read More

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options. Read More

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options. A key part of the design – telescoping, curved, concentric tubes – received U.S. patent protection in March 2019, the same month the principal investigators secured a $2.1 million R01... Read More

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia. Read More

Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs. Read More

Pietro Valdastri, assistant professor of mechanical engineering and electrical engineering, and postdoctoral scholar Ekawahyu Susilo will begin Valdastri’s second run as principal investigator in the NSF I-Corps program as they explore the commercial potential of modular open-source architecture for building capsule robots. Read More